PharmaceuticalCompanies
List your company
CompaniesCDMOsAPIGeographyShortagesPatent cliff
Register entry

Synergy Health AST, LLC

Request a quoteClaim this profile
Registered sites
11
Drug products
24
Live patents
0
Countries
7
Base
United States
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

sterilize
Sites

Facilities

11
SiteLocationOperationsFEI
STERIS Schweiz AGDaniken SOSwitzerlandsterilize3002808269
Synergy Health Radeberg GmbhRadebergGermanysterilize3002924544
Synergy Health MarseilleMarseilleFrancesterilize3002807041
Synergy Health Sterilisation UK LimitedDaventryUnited Kingdomsterilize3002807315
Synergy Health Sterilisation UK LimitedSwindonUnited Kingdomsterilize3010132111
Synergy Health Westport Ltd.WestportIrelandsterilize3002807036
Synergy Health Ede B.v.Ede GldNetherlandssterilize3002807038
Synergy Health Ede B.v.Etten-leurNetherlandssterilize3010223109
Synergy Health AST, LLCPetaluma, CAUnited Statessterilize3012102437
Synergy Health AST, LLCSan Diego, CAUnited Statessterilize1000518731
SYNERGY HEALTH AST, LLCSaxonburg, PAUnited Statessterilize3009882464
Catalogue

Marketed products

24

Showing 24 of 24.

BrandGeneric nameFormCategory
-Leuprolide AcetateINJECTION, SUSPENSION, EXTENDED RELEASEDRUG FOR FURTHER PROCESSING
-Leuprolide acetateINJECTION, SUSPENSION, EXTENDED RELEASEDRUG FOR FURTHER PROCESSING
-Leuprolide acetateINJECTION, SUSPENSION, EXTENDED RELEASEDRUG FOR FURTHER PROCESSING
-Olanzapine pamoateINJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASEDRUG FOR FURTHER PROCESSING
-Olanzapine pamoateINJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASEDRUG FOR FURTHER PROCESSING
-Olanzapine pamoateINJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASEDRUG FOR FURTHER PROCESSING
-Travoprost IntracameralIMPLANTDRUG FOR FURTHER PROCESSING
-afamelanotideIMPLANTDRUG FOR FURTHER PROCESSING
-bimatoprostIMPLANTDRUG FOR FURTHER PROCESSING
-cabotegravir and rilpivirinePOWDERDRUG FOR FURTHER PROCESSING
-dexamethasoneIMPLANTDRUG FOR FURTHER PROCESSING
-etonogestrelIMPLANTDRUG FOR FURTHER PROCESSING
-lanreotide acetateINJECTIONDRUG FOR FURTHER PROCESSING
-lanreotide acetateINJECTIONDRUG FOR FURTHER PROCESSING
-lanreotide acetateINJECTIONDRUG FOR FURTHER PROCESSING
-pasireotideINJECTION, POWDER, FOR SUSPENSIONDRUG FOR FURTHER PROCESSING
-pasireotideINJECTION, POWDER, FOR SUSPENSIONDRUG FOR FURTHER PROCESSING
-pasireotideINJECTION, POWDER, FOR SUSPENSIONDRUG FOR FURTHER PROCESSING
-pasireotideINJECTION, POWDER, FOR SUSPENSIONDRUG FOR FURTHER PROCESSING
-pasireotideINJECTION, POWDER, FOR SUSPENSIONDRUG FOR FURTHER PROCESSING
-triptorelinINJECTION, POWDER, LYOPHILIZED, FOR SUSPENSIONDRUG FOR FURTHER PROCESSING
-triptorelin pamoateINJECTION, POWDER, LYOPHILIZED, FOR SUSPENSIONDRUG FOR FURTHER PROCESSING
-triptorelin pamoateINJECTION, POWDER, LYOPHILIZED, FOR SUSPENSIONDRUG FOR FURTHER PROCESSING
-triptorelin pamoateINJECTION, POWDER, LYOPHILIZED, FOR SUSPENSIONDRUG FOR FURTHER PROCESSING
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.